Order Article Reprints

Nawar MF, Selim AA, Essa BM, El-Daoushy AF, Swidan MM, Chambers CG, Al Qahtani MH, Smith CJ, Sakr TM. Actinium-225/Bismuth-213 as Potential Leaders for Targeted Alpha Therapy: Current Supply, Application Barriers, and Future Prospects. Cancers. 2025; 17(18):3055. https://doi.org/10.3390/cancers17183055

Nawar, Mohamed F., Adli A. Selim, Basma M. Essa, Alaa F. El-Daoushy, Mohamed M. Swidan, Claudia G. Chambers, Mohammed H. Al Qahtani, Charles J. Smith, and Tamer M. Sakr. 2025. "Actinium-225/Bismuth-213 as Potential Leaders for Targeted Alpha Therapy: Current Supply, Application Barriers, and Future Prospects" Cancers 17, no. 18: 3055. https://doi.org/10.3390/cancers17183055

Nawar, M. F., Selim, A. A., Essa, B. M., El-Daoushy, A. F., Swidan, M. M., Chambers, C. G., Al Qahtani, M. H., Smith, C. J., & Sakr, T. M. (2025). Actinium-225/Bismuth-213 as Potential Leaders for Targeted Alpha Therapy: Current Supply, Application Barriers, and Future Prospects. Cancers, 17(18), 3055. https://doi.org/10.3390/cancers17183055